Koenig Sheldon L. 4
4 · Esperion Therapeutics, Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-17$2.47/sh−12,447$30,694→ 739,819 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.